JPRN-UMIN000027103已完成未知
The efficacy of anagliptin in patients with type 2 diabetes mellitus - Study for the efficacy of anagliptin
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with history of hypersensitivity to anagliptin 2.Patients with diabetic ketoacidosis, diabetic coma, or bofore coma, type1 diabetes 3.Severe infection, before and not long after surgery, or patient with severe trauma 4.Women with during pregnancy , nursing, or pregnant likelihood 5.Patients with severe renal dysfunction ,end stage renal disease during dialysis 6.Patients with severe liver dysfunction 7.Inadequte patient judged by doctor
研究者
相似试验
招募中
4 期
Clinical efficacy of anagliptin administration in type 2 diabetic patientsType 2 DiabetesJPRN-UMIN000011071Kuwana East Medical Center Cardiology40
已完成
不适用
ong-term efficacy of anagliptin in patients with type 2 diabetes mellitusType 2 Diabetes MellitusJPRN-UMIN000048203aka Kinen Clinic299
已完成
不适用
Evaluation of the clinical efficacy of anagliptin in type 2 diabetic patients with diabetic nephropathy.JPRN-UMIN000012802Kanazawa Medical University Diabetology and Endocrinology50
已完成
不适用
Study of the effect of Anagliptin administration on the activity of glucagon after test meal loadingPatients with type II diabetes mellitusJPRN-UMIN000021102Arc Cardiovascular Clinic20
已完成
不适用
The lipid lowering effect of anagliptin in type2 diabetes mellitus with dyslipidemiaType2 diabetes mellitus patients with dyslipidemiaJPRN-UMIN000013682Internal Medicine, Teikyo University School of Medicine40
